NCR3 and amyotrophic lateral sclerosis: The data also suggest that separate NK mechanisms may contribute to disease progression: unlike other surface markers, NKp30 expression increases as disease progresses, meaning that NKp30 may drive cytotoxicity in later stages of ALS.